Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,075 USD | +1,72% | -4,13% | -37,24% |
Métier
Nombre d'employés: 306
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Human Pharmaceutical Products
100,0
%
| 211 | 100,0 % | 257 | 100,0 % | +21,89% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 211 | 100,0 % | 257 | 100,0 % | +21,89% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 68 | 01/09/10 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 46 | 01/03/21 |
Chief Tech/Sci/R&D Officer | - | 01/12/21 | |
Rosh Dias
CTO | Chief Tech/Sci/R&D Officer | - | 15/03/22 |
Karen Kotz
SAM | Sales & Marketing | - | 01/08/22 |
Paul Reider
PRN | Corporate Officer/Principal | 55 | 01/01/21 |
Corporate Officer/Principal | - | 28/04/14 | |
Corporate Officer/Principal | 57 | 17/12/21 | |
Rebecca Sunshine
HRO | Human Resources Officer | 61 | 01/01/14 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mark Stolper
BRD | Director/Board Member | 52 | 05/01/21 |
Mats Wahlström
BRD | Director/Board Member | 70 | 01/01/12 |
Ali Satvat
BRD | Director/Board Member | 46 | 01/05/14 |
Lee Newcomer
BRD | Director/Board Member | 71 | 02/02/22 |
Denny Lanfear
CEO | Chief Executive Officer | 68 | 01/09/10 |
Georgia Erbez
BRD | Director/Board Member | 57 | 20/02 |
Director/Board Member | 68 | 18/05/22 | |
Michael Ryan
BRD | Director/Board Member | - | 18/07/23 |
Director/Board Member | 56 | 30/07/20 | |
Charles Newton
BRD | Director/Board Member | 53 | 05/05/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 113 498 415 | 108 865 391 ( 95,92 %) | 0 | 95,92 % |
Coordonnées société
Coherus BioSciences, Inc.
333 Twin Dolphin Drive Suite 600
94065, Redwood City
+650 649 3530
http://www.coherus.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-37,24% | 232 M | |
-2,60% | 103 Md | |
+1,78% | 95,28 Md | |
+1,46% | 22,15 Md | |
-15,61% | 21,02 Md | |
-8,58% | 18,15 Md | |
-38,74% | 16,73 Md | |
-12,46% | 16,05 Md | |
+5,78% | 13,68 Md | |
+34,35% | 12,17 Md |
- Bourse
- Actions
- Action CHRS
- Société Coherus BioSciences, Inc.